Epacadostat, nivolumab combination shows promise in certain advanced solid tumors

CHICAGO — Epacadostat in combination with nivolumab appeared safe and effective in patients with advanced melanoma and head and neck cancer, according to preliminary data from the ECHO-204 trial presented at the ASCO Annual Meeting.

Definitive Study Shows That People with Melanoma Do Not Need Immediate Lymph Node Removal

People with melanoma who test positive for cancer in their sentinel lymph node do not need to have their remaining regional lymph nodes immediately removed to improve their survival.

PDE-5 inhibitors and melanoma: No causal link found

Findings from a meta-analysis show that, while phosphodiesterase type 5 (PDE-5) inhibitor use is associated with a statistically significant increased risk of melanoma, they do not support a causal relationship, said lead author Stacy Loeb, MD, MSc, of NYU School of Medicine, New York.

Checkmate for Metastatic Brain Cancer

Researchers at the University of North Carolina Lineberger Comprehensive Cancer Center are helping to make strides in the treatment of metastatic melanoma that has spread to the brain.

Cancer in the News

Feature Articles

Cellular sweet spot found in skin-cancer battle

A team of researchers has pinpointed a sugar modification in cells that spurs the spread of skin cancer. Its findings, which appear in the latest issue of the journal Cancer Cell, spotlight a target in the battle against melanoma.

Read the full story

Posted in Melanoma In The News, Other Melanoma Research

VIDEO: Immune therapy effective, durable in treatment-naive melanoma brain metastases

CHICAGO – Immune therapy shows promise for use in the treatment of melanoma brain metastases, especially for treatment-naive patients, judging from the findings of a new phase II randomized study.

Read the full story

Posted in Melanoma In The News, OncLive Videos

Researchers find cellular sweet spot in skin-cancer battle

A team of researchers has pinpointed a sugar modification in cells that spurs the spread of skin cancer. Its findings, which appear in the latest issue of the journal Cancer Cell, spotlight a target in the battle against melanoma.

Read the full story

Posted in Melanoma In The News, Other Melanoma Research

Melanoma-Specific Survival With Completion Dissection vs Observation for Sentinel Node Metastasis

The phase III MSLT-II trial showed that completion dissection was not associated with improved melanoma-specific overall survival vs observation in patients with sentinel node metastasis, although a benefit was observed in regional disease control.

Read the full story

Posted in Melanoma In The News, Clinical Trials

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories